289 related articles for article (PubMed ID: 8875091)
1. A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.
Narayan KM; Hanson RL; Pettitt DJ; Bennett PH; Knowler WC
Diabetes Care; 1996 Sep; 19(9):972-8. PubMed ID: 8875091
[TBL] [Abstract][Full Text] [Related]
2. Comparison of screening tests for non-insulin-dependent diabetes mellitus.
Hanson RL; Nelson RG; McCance DR; Beart JA; Charles MA; Pettitt DJ; Knowler WC
Arch Intern Med; 1993 Sep; 153(18):2133-40. PubMed ID: 8379805
[TBL] [Abstract][Full Text] [Related]
3. The Fasting Hyperglycaemia Study: I. Subject identification and recruitment for a non-insulin-dependent diabetes prevention trial.
Hammersley MS; Meyer LC; Morris RJ; Manley SE; Turner RC; Holman RR
Metabolism; 1997 Dec; 46(12 Suppl 1):44-9. PubMed ID: 9439559
[TBL] [Abstract][Full Text] [Related]
4. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
[TBL] [Abstract][Full Text] [Related]
5. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.
Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS
Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423
[TBL] [Abstract][Full Text] [Related]
6. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
[TBL] [Abstract][Full Text] [Related]
7. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
8. Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.
Tai ES; Lim SC; Tan BY; Chew SK; Heng D; Tan CE
Diabet Med; 2000 Nov; 17(11):771-5. PubMed ID: 11131101
[TBL] [Abstract][Full Text] [Related]
9. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.
Meigs JB; Muller DC; Nathan DM; Blake DR; Andres R;
Diabetes; 2003 Jun; 52(6):1475-84. PubMed ID: 12765960
[TBL] [Abstract][Full Text] [Related]
10. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
[TBL] [Abstract][Full Text] [Related]
11. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.
Liu QZ; Pettitt DJ; Hanson RL; Charles MA; Klein R; Bennett PH; Knowler WC
Diabetologia; 1993 May; 36(5):428-32. PubMed ID: 8314447
[TBL] [Abstract][Full Text] [Related]
12. Fasting plasma glucose in screening for NIDDM in the U.S. and Israel.
Modan M; Harris MI
Diabetes Care; 1994 May; 17(5):436-9. PubMed ID: 7741837
[TBL] [Abstract][Full Text] [Related]
13. Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect?
Bourn DM; Mann JI; McSkimming BJ; Waldron MA; Wishart JD
Diabetes Care; 1994 Nov; 17(11):1311-9. PubMed ID: 7821173
[TBL] [Abstract][Full Text] [Related]
14. High risk of progression to NIDDM in South-African Indians with impaired glucose tolerance.
Motala AA; Omar MA; Gouws E
Diabetes; 1993 Apr; 42(4):556-63. PubMed ID: 8454106
[TBL] [Abstract][Full Text] [Related]
15. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.
Gabir MM; Hanson RL; Dabelea D; Imperatore G; Roumain J; Bennett PH; Knowler WC
Diabetes Care; 2000 Aug; 23(8):1108-12. PubMed ID: 10937506
[TBL] [Abstract][Full Text] [Related]
16. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of glycated hemoglobin in the early diagnosis of diabetes mellitus].
Qiu WS
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):407-9, 443-4. PubMed ID: 2591259
[TBL] [Abstract][Full Text] [Related]
18. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
Adam JM; Tarigan NP
Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
[TBL] [Abstract][Full Text] [Related]
19. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.
Ko GT; Chan JC; Tsang LW; Cockram CS
Diabetes Care; 2000 Dec; 23(12):1770-3. PubMed ID: 11128350
[TBL] [Abstract][Full Text] [Related]
20. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
